Contract facts
UnrestrictedNo full NAICS 334516 intel page yet. Browse NAICS intelligence
One (1) Year Firm-Fixed-Price Purchase Order for Preclinical Assessment of Naloxone Adequacy to Reverse Polysubstance is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by Charles River Laboratories, Inc. Estimated value $340K ($340K obligated). Current period of performance ends Sep 24, 2027. Last award drew 1 bidder. Place of performance: SILVER SPRING MD. Related solicitation 1292327.
One (1) year firm-fixed-price purchase order for preclinical assessment of naloxone adequacy to reverse polysubstance.
Recompete timing
PublicCurrent PoP ends Sep 24, 2027 (342 days remaining). Agencies typically plan 12–18 months ahead — at 11.2 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75F40126P00393? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordCharles River Laboratories, Inc — $210.9M obligated across 203 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40126P00393?
75F40126P00393 (One (1) year firm-fixed-price purchase order) is a Fda Office Of Acq Grant Svcs award with a potential value of $340K, currently held by Charles River Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40126P00393?
Fda Office Of Acq Grant Svcs awarded 75F40126P00393 to Charles River Laboratories, Inc (potential $340K).
Who is the incumbent on 75F40126P00393?
Charles River Laboratories, Inc is the incumbent with $210.9M across 203 related awards in SCOUT’s public footprint. The current period of performance ends Sep 24, 2027.
When does Charles River Laboratories, Inc’s 75F40126P00393 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 24, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75F40126P00393? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.